Seriously? "concept".... "paper".... Total value created by PPHM for ALL "concepts", and "papers" equals OVER 95% LOSS of shareholder value. In other words, completely meaningless as you should know from following this company for so long.
RE "acquiring Pharma from the book losses component of an acquisition"
I'll restate. BP/BB do NOT acquire little failed biotechs for the purpose of harvesting tax losses. They acquire them for the purpose of SALES and EARNINGS growth. PPHM has done ZERO to show they are anywhere near a drug that can do that in the coming YEARS.
Your premise is that IF PPHM were acquired, the value of the accumulated losses would add to value. It's not a relevant point because they've got nothing else anyone would pay for. So loop back to my prior paragraph again.